Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Lumefantrine-d9 | Benflumelol-d9; Benflumetol-d9; dl-Benflumelol-d9; | NA | C30H23D9Cl3NO | 538 | Benflumelol-d9; Benflumetol-d9; dl-Benflumelol-d9; |
| Dasabuvir | ABT 333; N-[6-[3-Tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide; | 1132935-63-7 | C26H27N3O5S | 493.57 | ABT 333; N-[6-[3-Tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide;
|
| Dasabuvir Naphthyl-d6 | ABT 333-d6; N-[6-[3-Tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide-d6; | NA | C26H21D6N3O5S | 499.61 | ABT 333-d6; N-[6-[3-Tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide-d6;
|
| (9E)-Lumefantrine | (9E)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methan | 1456736-33-6 | C30H32Cl3NO | 528.94 | (9E)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methan |
| Dasabuvir O-Trideuteromethyl-d3 | ABT 333-d3; N-[6-[3-Tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide-d3; | NA | C26H24D3N3O5S | 496.59 | ABT 333-d3; N-[6-[3-Tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide-d3;
|
| Dasatinib | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825; | 302962-49-8 | C22H26ClN7O2S | 488.01 | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825;
|
| Dasatinib-d8 | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl-d8]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825-d8; | 1132093-70-9 | C22H18D8ClN7O2S | 496.05 | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl-d8]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825-d8;
|
| Lumefantrine beta-D-Glucuronide | (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol beta-D-Glucopyranosiduronic Acid; | NA | C36H40Cl3NO7 | 705.06 | (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol beta-D-Glucopyranosiduronic Acid; |
| Dasatinib Carboxylic Acid | 4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic Acid; | 910297-53-9 | C22H24ClN7O3S | 501.99 | 4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic Acid;
|
| Dasatinib N-Oxide | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Oxide; | 910297-52-8 | C22H26ClN7O3S | 504 | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Oxide;
|
Page 1695 of 10017